Overcoming Regulatory Challenges In 3D Printing of Pharmaceuticals
What are the regulatory challenges faced by the 3D printing of pharmaceuticals, and how do we overcome them?
Overcoming Regulatory Challenges In 3D Printing of Pharmaceuticals
10 Strategies for Improving Patient Experience
Laxxon Medical's Commitment to Meeting and Exceeding CGMP Regulations In 3D Printed Pharmaceuticals
Methods to Reduce Patient Anxiety
The Importance of Improving Patient Experience for Women
Interview with Laxxon COO Klaus Kuehne
The Dangers of Prescription Medication and Drinking
Why are Adverse Drug Reactions Doubled in Women?
Digital Communication and Patient Experience
70% of Patients Believe Their Doctors Lack Empathy
3-Dimensional Screen Printing of Pharmaceuticals
The “Freezing of Gait” Effect From Levodopa Management of Parkinson Disease
Pharma Tech News & Development
An Interview with Helmut Kerschbaumer, Chief Executive Officer at Laxxon Medical
What Is Medical 3D Printing and How Is it Regulated?